MedPage Today (1/5, Robertson) reported, “Problems with the veterinary sedative xylazine – also known as ‘tranq’ – appeared to be concentrated in the eastern U.S. but were spread across the entire country, a cross-sectional study found.” Investigators found that “at least 43 states reported at least one xylazine-related overdose death from 2019 to 2022.” The data also indicated that “in 2019, 16 states had no xylazine forensic reports but by 2022, only two states had no such reports.” The findings were published in JAMA Network Open.
Related Links:
— MedPage Today (requires login and subscription)